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For stressed cells to induce the mitochondrial pathway of apoptosis, a cohort of pro-apoptotic BCL-2 pro-
teins must collaborate with the outer mitochondrial membrane to permeabilize it. BAK and BAX are the
two pro-apoptotic BCL-2 family members that are required for mitochondrial outer membrane permeabiliza-
tion.While biochemical and structural insights of BAK/BAX function have expanded in recent years, very little
is known about the role of the outer mitochondrial membrane in regulating BAK/BAX activity. In this review,
we will highlight the impact of mitochondrial composition (both protein and lipid) and mitochondrial inter-
actions with cellular organelles on BAK/BAX function and cellular commitment to apoptosis. A better
understanding of how BAK/BAX and mitochondrial biology are mechanistically linked will likely reveal novel
insights into homeostatic and pathological mechanisms associated with apoptosis.‘‘I kissed thee ere I killed thee. No way but this, Killing
myself, to die upon a kiss.’’
—William Shakespeare (1564–1616); Othello
Programmed cell death (PCD) is a genetically controlled
mechanism of removing stressed or unnecessary cells within
multicellular organisms. Apoptosis is the most common form of
PCD, and apoptotic mechanisms are divided into two major
pathways. The ‘‘extrinsic pathway’’ is induced by extracellular
death ligands and cognate death receptors (e.g., tumor necrosis
factor-a [TNF-a]); and the ‘‘intrinsic pathway,’’ which responds to
intracellular stress signaling (e.g., macromolecular damage), is
mediated by mitochondria.
Throughout the past two decades, significant research efforts
have focused on understanding the mechanistic contribution of
mitochondria to the intrinsic pathway of apoptosis. Kerr, Willie,
and Curie published a groundbreaking observation in 1972,
which identified the morphological features of PCD and intro-
duced the concept of ‘‘apoptosis.’’ One of the observations
within that manuscript was that mitochondria remain intact dur-
ing the early stages of apoptosis (Kerr et al., 1972)—therefore,
how do mitochondria communicate a signal to induce cell
death?
In 1990, the anti-apoptotic function of the oncogene B cell
lymphoma 2 (BCL-2) was shown to rely on mitochondrial locali-
zation (Hockenbery et al., 1990, 1993); and soon after, cyto-
chrome c release was identified as the mitochondrial signal
required for apoptosis (Liu et al., 1996; Kluck et al., 1997; Manon
et al., 1997). It is now well established that the BCL-2 family of
proteins primarily regulate the release of mitochondrial inter-114 Chemistry & Biology 21, January 16, 2014 ª2014 Elsevier Ltd Allmembrane space (IMS) proteins that activate the cell death
proteases called caspases. These proteases are responsible
for many of the apoptotic hallmarks first identified by Kerr and
colleagues, including nuclear condensation and cellular contrac-
tion. In addition to cytochrome c, two other IMS proteins that
directly contribute to the initiation phases of apoptosis are sec-
ond mitochondrial-derived activator of caspases (SMAC; Du
et al., 2000; Verhagen et al., 2000) and Omi/HtrA2 (Srinivasula
et al., 2003; Yang et al., 2003). The release of these pro-
apoptotic factors from the IMS requires a loss of outer mitochon-
drial membrane (OMM) integrity, which is directly initiated by the
pro-apoptotic members of the BCL-2 family in a process termed
mitochondrial outer membrane permeabilization or ‘‘MOMP.’’
Through MOMP, the pro-apoptotic IMS proteins re-localize to
the cytosol to initiate caspase activation, and this process gen-
erates the mitochondrial signal required for the intrinsic pathway
to proceed.
Here we will present a current interpretation of how the BCL-2
family functions, and how the pro-apoptotic BCL-2 members
collaborate to induce MOMP (Figure 1). Importantly, we will
discuss BCL-2 family function and MOMP within the context
of both mitochondrial composition and biology for two key
reasons: (1) pro-apoptotic BCL-2 proteins functionalize at the
OMM to promote MOMP, and (2) recent evidence supports a
novel role for both mitochondrial proteins and lipids in the regu-
lation of MOMP. The second reason is of significant interest as it
suggests that mitochondria play an active role in the recruitment
and activation of the pro-apoptotic BCL-2 family members by
regulating the proteins and lipids at the OMM. In addition, the
notion that specific lipids and lipid metabolic pathways directlyrights reserved
Figure 1. Mechanisms of BAK/BAX Activation within the BCL-2
Family
Pro-apoptotic effectors (e.g., BAX, in blue) require multiple conformational
changes to induce MOMP. Activation-associated BAK/BAX conformational
changes are induced by interactions with direct activator BH3-only proteins
(e.g., BIM, in yellow). These conformational changes are: exposure of the N
terminus, exposure of the a9 helix revealing the BH3 domain and, in some
cases, homodimerization. Subsequently, multimerization of these dimers
leads to pore formation and apoptosis. Anti-apoptotic proteins (e.g., BCL-2, in
red) prevent MOMP in two ways: (1) anti-apoptotic proteins actively sequester
pro-apoptotic BH3-only proteins, and (2) anti-apoptotic proteins bind to
the exposed BH3 domain of BAK and BAX to prevent dimerization and
oligomerization. Sensitization is when BH3-only proteins (e.g., BIM, in yellow)
are binding anti-apoptotic proteins, preventing the future inhibition of pro-
apoptotic proteins. Derepression is when a BH3-only protein (e.g., BAD, in
green) releases activated BAK/BAX monomers and/or direct activator pro-
teins, from anti-apoptotic proteins, leading to MOMP.
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bers reveals that heterotypic membrane interactions and lipid-
trafficking pathwaysmay play novel roles in cell death regulation.
The BCL-2 Family: Regulators of Outer Mitochondrial
Membrane Integrity
The BCL-2 family is divided into three groups based on structural
and functional homologies. The proteins are composed mostly
of a helices and share up to four homology domains termed
BCL-2 homology (BH) domains. Most multidomain members
(i.e., those with two or more BH domains, for example BCL-2)
and BID (a BH3-only member, described below) possess a
similar tridimensional structure (Yan and Shi, 2005), whereas
the remaining BH3-only proteins are intrinsically unstructured
in solution and fold upon interactions withmultidomain members
(Hinds et al., 2007; Petros et al., 2000).
The anti-apoptotic BCL-2 proteins are responsible for main-
taining the integrity of the OMM. They are globular proteins
that contain BH domains 1–4. The members of this subfamily
include A-1 (BCL-2 related gene A1), BCL-2, BCL-xL (BCL-2
related gene, long isoform), BCL-w, andMCL-1 (myeloid cell leu-
kemia 1). These proteins are generally found at theOMM, but can
also be localized to the endoplasmic reticulum (ER) membrane
and in the cytosol. The anti-apoptotic BCL-2 proteins preserve
OMM integrity by directly binding to both classes of pro-
apoptotic BCL-2 proteins (i.e., the BH3-only and effector pro-
teins), which prevents them from cooperating to induce MOMP
and subsequent apoptosis. The anti-apoptotic members share
a conserved ‘‘BCL-2 core’’ structure comprised of six a helices,
which results in the formation of a hydrophobic groove. Although
the anti-apoptotic BCL-2 proteins demonstrate conserved
sequence and/or structural homologies, slight variations within
this groove afford unique binding profiles between the anti-
apoptotic and pro-apoptotic proteins.Chemistry & BioloThe pro-apoptotic multidomain proteins BAK (BCL-2 antago-
nist killer 1) and BAX (BCL-2-associated X protein) are the
effectors of MOMP as they insert into the OMM and induce the
formation of pores allowing for the release of IMS proteins (Liu
et al., 1996; Kluck et al., 1997; Figure 1). ForBAKorBAX to induce
MOMP, these proteins must be localized to the OMM and acti-
vated by a BH3-only protein. For BAK, the mechanism of activa-
tion is more straightforward because the protein is constitutively
inserted in the OMM by its a9 helix (Moldoveanu et al., 2006). In
contrast, BAX activation requires additional steps because this
protein is generally cytosolic and must interact with the OMM
to undergo activation (Hsu et al., 1997; Wolter et al., 1997) and
trigger MOMP (Manon et al., 1997; Ju¨rgensmeier et al., 1998).
Upon activation by BH3-only proteins (Kuwana et al., 2002;
Gavathiotis et al., 2008; Lovell et al., 2008; Kimet al., 2009), phys-
ico-chemical changes (Khaled et al., 2001; Cartron et al., 2004),
or in vitro interactions with hydrophobic molecules (e.g., deter-
gents [Hsu and Youle, 1997] or fatty aldehydes [Chipuk et al.,
2012]), BAX and BAK undergo multiple conformational changes
including the exposure of the a1 helix (Cartron et al., 2005; Peyerl
et al., 2007), the a9 helix (Gavathiotis et al., 2008; Kim et al., 2009;
Czabotar et al., 2013), and the BH3 domain (Cartron et al., 2005);
insertion of their a5–6 helices in theOMM (Annis et al., 2005; Gar-
cı´a-Sa´ez et al., 2006), dimerization, and higher order oligomeriza-
tion (Eskes et al., 2000; Antonsson et al., 2001). Once activated,
the oligomerized forms of BAK and BAX form proteolipid pores
within the OMM, and these pores are large enough for themajor-
ity of soluble IMS proteins to escape into the cytosol.
The third subgroup comprises proteins in which homology to
theBCL-2 family is restricted to theBH3domain, and thesemem-
bers are commonly referred to as ‘‘BH3-only proteins.’’ These
function by directly associating with both the anti-apoptotic
and effector proteins; this leads to two distinct mechanisms of
action for the BH3-only members (Figure 1). First, all BH3-only
proteins have the ability to bind anti-apoptotic proteins with rela-
tive binding specificities, which either neutralizes anti-apoptotic
function to decrease cellular sensitivity to MOMP (e.g., BAD), or
releases previously sequestered BH3-only proteins to directly
induce MOMP (e.g., PUMA) (Kuwana et al., 2005; Letai et al.,
2004; Chipuk et al., 2008). In the latter statement, the second
mechanism of BH3-only protein function is revealed, which is a
subgroup of BH3-only proteins can act as direct activators to
BAK and BAX to induce their oligomerization and pore-forming
activity: for example, BID (Desagher et al., 1999; Wei et al.,
2000) and BIM (Gavathiotis et al., 2008; Kim et al., 2009).
As described above, the BCL-2 family participates in MOMP
by controlling the formation of pores in the OMM (Figure 2). How-
ever, the interplay between the BCL-2 family andmitochondria is
not limited to the intrinsic pathway. Numerous BCL-2 family
members play an active role in the regulation of mitochondrial
dynamics, and subsequently, mitochondrial metabolism in
healthy cells. Mitochondrial fusion is regulated by BCL-xL
through the interaction with a large GTPase in the OMM, Mitofu-
sin-2 (Mfn2; Delivani et al., 2006). Similarly, BAK and BAX also
enhance mitochondrial fusion in nonapoptotic (Hoppins et al.,
2011; Karbowski et al., 2006) and apoptotic cells (Brooks
et al., 2007), by interaction with Mfn-2 (Hoppins et al., 2011).
These observations suggest that mitochondria are not a passive
target of the BCL-2 family, but that a broader cooperation exists.gy 21, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 115
Figure 2. Competing Models of Pore
Formation during Apoptosis
In the literature, there are several models
describing the composition of the pore respon-
sible for cytochrome c release. Early models of
apoptosis suggested that BAK and BAX can
positively influence proteinaceous or lipidic pore
formation. For example, it has been shown that
BAX increases the permeability of VDAC1 function
in the OMM; alternatively, BAK/BAX may coop-
erate with ceramide channels. On the other hand,
biochemical studies have shown that BAK and
BAK directly promote pore formation in the
absence of additional proteins. More recently,
accumulating evidence suggests that BAK/BAX
and mitochondrial lipids cooperate to promote
BAK/BAX activation and pore formation.
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mented, and the process of autophagy directly affects organelle
turnover and cellular metabolism (Levine et al., 2008).
Throughout our discussion so far, we have focused on the
function of BCL-2 protein to regulate apoptosis, but little atten-
tion has been paid to understanding how mitochondria affect
the BCL-2 family to induce MOMP. Are mitochondria passive
organelles in the process or do they regulate their own permea-
bilization by creating an environment that is permissive for pro-
apoptotic BCL-2 members to engage MOMP? We will directly
address these questions in the following sections.
The Outer Mitochondrial Membrane: A Unique Platform
for BCL-2 Family Function
Nearly all the multidomain members of the BCL-2 family are
localized to the OMM, but there are instances of cytosolic and
inner mitochondrial membrane localizations, such as BAX and
MCL-1, respectively (Hsu et al., 1997; Perciavalle et al., 2012).
The mitochondrial localization of the BCL-2 proteins is favored
by a combination of a-helical bundles that comprise the core
structural components of the folded members, a carboxyl
terminus transmembrane domain, hydrophobic patches of the
proteins, and posttranslational modifications that promote pro-
tein-membrane interactions (e.g., N-myristoylation of BID; Zha
et al., 2000).
One of the intriguing questions about the BCL-2 family of pro-
teins is what dictates their predilection for the OMM? Unlike
most of mitochondrial proteins, BCL-2 family members do not
possess a well-defined mitochondrial targeting sequence. The
presence of several positively charged residues in the trans-
membrane helix of BCL-xL favors its mitochondrial localization;
however, this is not the case for BCL-2 (Kaufmann et al.,
2003). Because the majority of BCL-2 family members do not
have a carboxyl terminus with multiple positively charged amino
acid residues, it is unlikely that such a signal dictates the target-
ing to the OMM. More likely, BCL-2 family localization and
function are favored by the environment of the OMM itself via a
combination of mitochondrial proteins and lipids.
Indeed, most of the anti-apoptotic BCL-2 members are
localized to the OMM via a carboxyl terminus transmem-
brane domain. This serves as an efficient docking element for
regulating pro-apoptotic BCL-2 proteins, which bind to anti-
apoptotic members via their BH3 domain. It is likely that most
BH3-only proteins localize to the OMM by direct associations
with the anti-apoptotic repertoire. One exception is BID, which116 Chemistry & Biology 21, January 16, 2014 ª2014 Elsevier Ltd Allappears to directly bind membranes to reveal its BH3 domain
and induce apoptosis. However, neither protein nor membrane
interactions exclude subsequent exchanges; more specifically,
if BID is first bound to a membrane, this could serve as an effi-
cient mechanism to eventually position BID into the hydrophobic
groove of a pro- or an anti-apoptotic BCL-2 member.
Furthermore, there are several proteins that serve as ‘‘recep-
tors’’ to promote the mitochondrial localization of BCL-2 family
members, including multiple components of the mitochondrial
import machinery (i.e., the TOM complex) and the mitochondrial
carrier protein MTCH2, both of which have been suggested to
play a role in the incorporation of the BCL-2 proteins into the
OMM (Zaltsman et al., 2010). Significant efforts have focused
on understanding how BAX is recruited to the OMM to promote
apoptosis. As mentioned earlier, BAX is dynamically associated
with the mitochondrial membrane in healthy cells (Hsu et al.,
1997). Several studies recently suggested that mitochondrial
BAX in nonapoptotic cells results from a translocation/retro-
translocation to and from the mitochondria (Edlich et al., 2011;
Renault et al., 2013; Schellenberg et al., 2013). Multiple mem-
bers of the BCL-2 family have been shown to modulate BAX
mitochondrial localization. For example, BCL-2, BCL-xL, and
MCL-1 increased both BAX translocation to (Renault et al.,
2013; Schellenberg et al., 2013) and retrotranslocation from
(Edlich et al., 2011; Schellenberg et al., 2013) the OMM. Upon
triggering of apoptosis, BH3-only proteins (e.g., BID and BIM)
can stimulate the mitochondrial localization of BAX, and accu-
mulation into the OMM (Hsu et al., 1997; Kuwana et al., 2002).
After BAX is at the OMM, additional protein may serve to pro-
mote activation, such as the mitochondrial division protein
DRP-1 that stimulates BAX oligomerization through the remodel-
ing of the OMM (Montessuit et al., 2010).
As we have alluded to throughout our discussion, BCL-2 fam-
ily members function in the context of mitochondrial mem-
branes, and the proteins involved in localizing the BCL-2 family
to the OMM are either constitutively membrane bound and/or
regulate the OMM directly. Therefore, we propose that the lipid
environment has at least two key roles in regulating cellular
sensitivity to apoptosis: (1) anti-apoptotic and pro-apoptotic
proteins likely have a specific lipid requirement to efficiently
interact to either promote cellular survival or engage apoptosis,
and (2) for the above interactions to take place, the membrane
environment must be able to localize and/or deliver BCL-2 pro-
teins to the OMM. Below, we will discuss these two key roles
of the OMM.rights reserved
Figure 3. Mitochondrial Lipids Regulate BAK/BAX Activation and
MOMP
BAK/BAX activation requires several conformational changes, including
intramolecular (N terminus exposure, core conformational changes revealing
the BH3 domain) and intermolecular (homodimerization and oligomerization)
rearrangements. Several lipids are described to cooperate with BID, BAK,
and BAX. As a first example, cardiolipin favors BID interactions with BAK and
BAX, which promotes intramolecular conformational changes. Given the
abundance of cardiolipin in the IMM and contact sites, additional roles for
cardiolipin in BAK/BAX core rearrangements and oligomerization remain
to be resolved. Additionally, sphingosine-1-phosphate and hexadecenal are
demonstrated to participate in BAK and BAX activation, respectively. The
exact step(s) of BAK/BAX activation controlled by these sphingolipid metab-
olites also remains to be defined. Little is known about the negative regulatory
aspects of lipids on BAK and BAX activation, except for phosphatidyletha-
nolamine, which inhibits BAX oligomerization in vitro.
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After the discovery of the nearly 20 BCL-2 family members and
the identification of anti- and pro-apoptotic phenotypes associ-
ated with each member, significant effort focused on under-
standing how the multiple members of the pro-apoptotic
subfamilies collaborated to induce MOMP. One of the major
advances in the field stemmed from a paper by Kuwana and col-
leagues that shows BAX, BID, and mitochondrial lipids coop-
erate to permeabilize membranes. The authors determined the
lipid composition of mitochondrial membranes, and then estab-
lished a biochemically defined, protein-free large unilamellar
vesicle model system that mimics the composition of the
OMM. The OMM is comprised of several ubiquitous lipids,
including phosphatidylcholine, phosphatidylethanolamine,
phosphatidylinositol, and phosphatidylserine; along with small
amounts of phosphatidic acid and a debatable level of cardioli-
pin (n.b., we will discuss cardiolipin in the next section). That
said, BAX-dependent permeabilization of these ‘‘mitochondrial
LUVs’’ required a high percentage of cardiolipin. Similar require-
ments for BAK have not been formally tested, but BAK also
works in LUV systems similar to those described above (Kuwana
et al., 2002; Du et al., 2011; Leshchiner et al., 2013).
Given the abilities of BAK and BAX to activate, oligomerize,
and permeabilize in the OMM independently of mitochondria
proteins, it was further hypothesized that BAK and BAX are suf-
ficient to form a proteinaceous pore. Kinetic analysis suggested
that the BAX pore assembles progressively, and is formed by 9–
12 BAXmonomers that would correspond to a size of about 6 nm
(Martinez-Caballero et al., 2009; Kushnareva et al., 2012). Larger
BAX and BAK oligomers (between 100 and 2 3 104 BAX units)
have also been identified in vitro (Nechushtan et al., 2001;
Zhou and Chang, 2008), but physiological requirements for
such large pores have not been demonstrated.
In parallel, one additional important detail is that BAX can
destabilize lipid bilayers at very low concentrations (Basan˜ezChemistry & Bioloet al., 1999), suggesting that membrane permeabilization may
not be exclusively due to the formation of a proteinaceous pore,
but there may be contributions of the lipid reorganization within
themembrane that causeMOMP (Figure 3). Thismodel suggests
that lipids rearrange to form a toroidal structure involving a local
fusion of the two leaflets of the bilayer membrane and suggests
that BAK andBAXwould play a role in the organization and stabi-
lization of the lipids. This ideawas first supported by the observa-
tion that the lipid compositionof themembranewascritical for the
formation of a BAK/BAX channel. Indeed, in the toroidal model,
lipids are subjected to nonplanar constraints, which are favored
by the presence of lipids with a positive intrinsic curvature (e.g.,
lysophosphatidylcholine) and to a lesser extent, lipids with a
negative intrinsic curvature (e.g., phosphatidylethanolamine).
Both positively and negatively curved lipids have been shown to
stimulate the BAX-mediated permeabilization of liposomes (Ba-
san˜ez et al., 2002; Terrones et al., 2004) viaBAXa5 anda6helices
(Garcı´a-Sa´ez et al., 2006). In contrast to b-barrel channels for
which a structure can be determined by crystallization, it is very
difficult to obtain structural information on a helix structured
pore-forming proteins. However, structural data was acquired
using BAX a5 helix and further supported the model of a toroidal
lipidic pore (Qian et al., 2008); andmore recently, structural inter-
rogations of BAX dimers will surely lead us onto a path of a better
understanding of the BAK and BAX pores (Czabotar et al., 2013).
Does Cardiolipin Regulate BAK/BAX-Dependent
MOMP?
Cardiolipin (CL), or 1,3-bis-(sn-30-phosphatidyl)-sn-glycerol, is
one of the major lipids synthesized and localized in the IMM
(13%); and CL plays a key structural role in the junction sites
between the IMM and OMM (Hoch, 1992; Zhang et al., 2011).
CL also directly binds to cytochrome c at the IMM, and is there-
fore thought to be an important regulator of apoptosis (Iverson
et al., 2004; Choi et al., 2007); likewise, a deficiency in CL facili-
tates cytochrome c release and apoptosis (Choi et al., 2007).
As mentioned earlier, CL is required for BAX-induced permeabi-
lization of mitochondrial LUVs (Kuwana et al., 2002; Terrones
et al., 2004; Figure 3). Interestingly, LUVs that resemble the lipid
composition of the endoplasmic reticulum (ER) resist BAX-medi-
ated permeabilization unless CL is added (Kuwana et al., 2002).
However, deletion of CL synthase in yeast expressing human
BAX has no effect on BAX insertion into the OMM and sub-
sequent cytochrome c release (Iverson et al., 2004), which sug-
gests that CL is not absolutely essential for BAX-dependent
membrane permeabilization, or perhaps CL can be substituted
with other factors (Du et al., 2011).
While the published literature describing a role for CL in BAX
function at the OMM remains debated, additional roles for CL
in BCL-2 family function have also been suggested. CL promotes
BID translocation to liposomes (Garcı´a-Sa´ez et al., 2009), to
the OMM (Lutter et al., 2000), and to mitochondrial contact
sites (Lutter et al., 2001). CL also assists in the recruitment and
activation of caspase 8 to the OMM, which may function as an
activation platform for BID cleavage (Gonzalvez et al., 2008).
Within BID, there is a CL-binding domain that resides within
amino acids 103–163 spanning a helices 4, 5, and 6 (Lutter
et al., 2000). This CL-binding domain is directly implicated in
targeting BID to the OMM because cells expressing agy 21, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 117
Figure 4. Interorganellar Communication Influences Mitochondrial
Lipid Composition and MOMP
Because the permeabilization of the OMM is effected and affected by lipids,
interactions between the OMM and other cellular membranes likely influence
BAK/BAX activation and MOMP. For example, lipids originating at the Golgi
complex and ER influence the composition of mitochondrial membranes (e.g.,
sphingomyelin, ceramide, and phosphatidylserine). Likewise, this transfer
increases the diversity of mitochondrial lipids as mitochondria themselves are
able to further metabolize lipids that directly affect BAK/BAX activation (e.g.,
sphingosine-1-phosphate, hexadecenal, and phosphatidylethanolamine).
Lipid transfer is likely assisted by a combination of shared membrane struc-
tures and proteinaceous tethers between the ER and mitochondria (e.g., the
ERMES complex andMfn-2 dimers). In addition to a role in lipid exchange, ER-
mitochondria interactions also allow for calcium buffering between organelles,
which modulates the sensitivity of mitochondria to the BCL-2 family.
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localize exogenously expressed BID (Lutter et al., 2000).
BID localizes and activates at the OMM, but is there a role for
CL on BID-induced MOMP after recruitment (Figure 3)? Perhaps
the sole role of CL is to promote BID-induced BAX activation and
membrane permeabilization? The answer is likely no, however,
because additional reports suggest that BID can also have direct
consequences on membrane integrity, lipid mixing between the
IMM and OMM, and membrane curvature (Epand et al., 2002)—
all of which are directly affected by the presence of CL and its
metabolism. Furthermore, the role of CL likely extends beyond
BID and BAX, as a truncated form of BAK directly binds CL re-
sulting in heighted sensitivity to BID-induced BAK activation
and membrane permeabilization (Landeta et al., 2011). As noted
above, CL is described to affect BAK, BAX, and BID function, this
begs the question: are anti-apoptotic BCL-2members also regu-
lated? There is currently no answer to this question.
Alternatively, a role for CL in BAK/BAX-dependent apoptosis
can be debated for at least two reasons: (1) the CL concentration
required for membrane permeabilization in vitro is below the
physiological level observable in the OMM, and (2) in vitro acti-118 Chemistry & Biology 21, January 16, 2014 ª2014 Elsevier Ltd Allvation of BAX and subsequent membrane permeabilization can
occur in the absence of CL (Chipuk et al., 2012; Xu et al.,
2013). However, thorough biochemical and cellular studies using
mammalian systems and endogenous components are neces-
sary to generate conclusions. Furthermore, because BAK,
BAX, BID, and CL likely regulate mitochondrial cristae junction
organization during MOMP (Scorrano et al., 2002; Yamaguchi
et al., 2008), which affects cytochrome c accessibility to the
cytosol, we also may have to explore alternative regulatory com-
ponents to fully appreciate the potential dual role of CL inMOMP.
Whereas CL synthesis occurs within mitochondria, numerous
lipids found in the OMM originate from distinct cellular mem-
branes. Mitochondria themselves biochemically and physically
interact with a host of membrane structures, e.g., the ER, is it
possible that these interactions regulate the composition of the
OMM, which have immediate implications on pro-apoptotic
BCL-2 family function? We will explore this question in the
following section.
Contact Sites between the ER and Mitochondria: A
Regulator of BAK/BAX Activation and Cell Death?
The ER network represents a significant proportion of a cell’s
total membrane structure, and the ER interacts with multiple or-
ganelles via membrane-membrane contacts, along with protein-
aceous tethers between the organelles (Elbaz and Schuldiner,
2011). Regarding a direct interaction between the ER and
OMM, there are proteinaceous tethers that link the two mem-
branes at a distance of approximately 10–20 nm, but the identity
of these protein(s) remains controversial. The pro-fusion GTPase
Mfn2 is suggested as an ER-mitochondrial tether, because its
deletion results in marked changes in ER network morphology
and a decrease in mitochondrial proximity (de Brito and Scor-
rano, 2008). However, the effect of mfn2 deletion generates a
phenotype in only 40% of mitochondria, suggesting multiple
tethering proteins may exist. Indeed, a genetic screen searching
for mitochondria/ER disruptions in yeast identified a tethering
complex named ER-mitochondria encounter structure (ERMES),
which comprises the ER protein Mmm1 and the mitochon-
drial proteins Mdm10/34 and Mdm12 (Kornmann et al., 2009;
Figure 4), But, what is the evidence that ER-mitochondrial
contact regulates MOMP and apoptosis?
To address this question, we must focus on the physiolog-
ical roles of ER-mitochondrial communication. Mitochondria
demonstrate excellent buffering capacity against calcium
release from the ER, and when mitochondrial-ER tethering is
increased by the introduction of recombinant tethers, there are
impressive increases to mitochondrial calcium uptake that may
directly influence cellular sensitivity to apoptosis by the recruit-
ment of pro-apoptotic BCL-2 proteins (Csorda´s et al., 2006,
2010). Another function of ER - mitochondrial tethering is the
regulation of phospholipid synthesis and translocation between
the organelles as phosphatidylcholine (PC) synthesis requires
crosstalk between ER and mitochondria. Phosphatidylserine
(PS), a PC precursor, is synthesized in the ER network and
must translocate to the mitochondrial IMS to be converted to
phosphatidylethanolamine (Stone and Vance, 2000), which
returns to the ER to be converted to PC. As evidence, deletion
of critical components of the ERMES complex leads to changes
in bothmitochondrial morphology and collateral decreases in PSrights reserved
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mation available on the role of phospholipids on BCL-2 family
function, but one study revealed that the presence of phospha-
tidylethanolamine (PE) does not affect BAX insertion into amem-
brane, but PE is inhibitory to BAX oligomerization. As with all
membranes, a balance between each lipid species is essential
for homeostasis, and we have little information on how disrup-
tions to phospholipid levels directly affect BAK/BAX function.
Another aspect of ER-mitochondrial communication that likely
affects BAK/BAX function is the dual role of the mitochondrial
dynamics machinery in tethering. As mentioned above, Mfn2
tethers the ER to the mitochondrial network. However in healthy
cells, BAX also localizes to the sites of mitochondrial fusion,
interacts with Mfn-2, and stimulates mitochondrial fusion (Kar-
bowski et al., 2006). Mechanistically, the monomeric form of
BAX promotes the homodimerization of Mfn2 to induce mito-
chondrial fusion (Hoppins et al., 2011); these observations may
also provide some insights for the observation that BAX localizes
on the ER membrane (Scorrano et al., 2003; Zong et al., 2003).
An additional function of ER-mitochondrial interactions may be
the physical requirement for ER tubules to mark the mitochon-
drial network for sites of mitochondrial division, which is medi-
ated by Drp1 assembly (Friedman et al., 2011). Likewise, there
is a significant literature describing a role for Drp1 in mediating
BAX localization and activation, along with mitochondrial mem-
brane rearrangements, that are necessary to support MOMP.
One more role for ER-mitochondrial tethering may be to
directly provide a source of cellular sphingolipids to the mito-
chondrial membranes (and vice versa). There is a substantial
literature supporting a role for sphingolipids in regulating cellular
sensitivity to BAK/BAX activation, but synthetic pathways and
transport mechanisms for sphingolipids into the OMM require
further study. The shuttling of ceramides between the ER and
Golgi complex and other cellular organelles is mediated by
CERT (ceramide transporter), GLTP (glycolipid transport pro-
tein), and saposins. While little is known regarding the flow of
sphingolipids from heterotypic membranes to mitochondria,
we will discuss the role of various sphingolipids in mediating
BAK/BAX activation and apoptosis in the following section.
Sphingolipids: Multiple Intersections with the BCL-2
Family
Sphingolipids are a complex and diverse set of lipids that are
characterized by a sphingoid base linked to a fatty acid via an
amide bond. These lipids are essential for cellular membrane
structures and signal transduction. The role of these lipids in
signaling ranges from survival pathways to the biochemical deci-
sion to induce cell death, and encompasses almost everything
in between (e.g., autophagy, metabolism, signaling cascades,
membrane trafficking, and organelle integrity). A discussion on
all the possible roles of every sphingolipid in cell survival and
cell death pathways is not possible here, but we will present
three distinct topics that are directly linked to the BCL-2 family
and pro-apoptotic signaling: (1) ceramides induce pore forma-
tion in the OMM that is regulated by the BCL-2 family, (2)
the BCL-2 family regulates cellular sphingolipid composition
following cellular stress, and (3) multiple sphingolipids cooperate
with BAK and BAX to promote MOMP (Figure 3). In brief, these
topics reveal that BCL-2 family function and multiple sphingoli-Chemistry & Biolopid species collaborate to promote MOMP, but the molecular
mechanisms behind these interactions and phenotypes remain
mostly unknown.
Before the mechanisms of BCL-2 family regulated apoptosis
were identified, early studies revealed that the addition of C2-
ceramide (a cell-permeable synthetic analog of ceramide) to
leukemic cells in vitro led to inter-nucleosomal DNA cleavage
and apoptosis (Obeid et al., 1993). Similarly, cancer cell lines
treated with TNF-a displayed increased sphingomyelin hydroly-
sis, ceramide accumulation, and subsequent apoptosis (Dress-
ler et al., 1992; Obeid et al., 1993; Geilen et al., 1997). These
observations suggested that ceramide itself was necessary
and sufficient to induce apoptosis, and led to numerous studies
showing that ceramide could form pores in lipid membranes,
which was then implicated as a mediator of cytochrome c
release in cells. Indeed, ceramide forms pores in planar mem-
branes; and similar results can be obtained using isolated mito-
chondria suggesting that ceramide may be able to induce
cytochrome c release directly (Siskind and Colombini, 2000;
Siskind et al., 2002). Interestingly, several members of the
anti-apoptotic BCL-2 family have been shown to modulate
the pore-forming activity of ceramide. For instance, the
anti-apoptotic proteins BCL-2 and BCL-xL, along with the
Caenorhabditis elegans BCL-2 homolog CED-9, disassemble
ceramide channels in isolated mitochondrial systems from rat
and yeast (Siskind et al., 2008), potentially through direct interac-
tions between ceramide and the anti-apoptotic protein (Perera
et al., 2012). Conversely, BAX is described to synergize with
various ceramides to permeabilize both planar membranes and
isolated mitochondria. Although BAX and ceramide possess in-
dependent pore-forming functions, the combination of BAX and
ceramide leads to an enhanced permeabilization (Ganesan et al.,
2010). However, it remains unknown if BAX stabilizes the forma-
tion of ceramide pores or if ceramide promotes BAX insertion
and oligomerization; potentially, the two mechanisms are not
mutually exclusive. However, the use of a mitochondrially tar-
geted analog of ceramide (C6-pyridinium) demonstrated a posi-
tive role for ceramide on BAX-induced MOMP and apoptosis in
the absence of BID suggesting that perhaps ceramide specif-
ically promotes BAX function (Hou et al., 2011).
In cells, it is difficult to directly determine the effects of sphingo-
lipids on individual BCL-2 proteins because of the multiple roles
these lipids play in cellular homeostasis and the exquisite
compensatory mechanisms that are activated when the meta-
bolism of one sphingolipid species is altered. However, an inter-
esting set of observations revealed that the subcellular location
of ceramide generation has differential effects on apoptosis.
The pro-apoptotic contributions of ceramide generation in
different cellular compartments was determined by targeting a
bacterial neutral sphingomyelinase to various organelles and re-
vealed that ceramide-induced apoptosis relies on mitochondrial
ceramide (Birbes et al., 2001). Interestingly, apoptosis induced
by mitochondrial ceramide is dependent upon BAX recruitment
to mitochondria, cytochrome c release, and is inhibited by the
overexpression of BCL-2 (Birbes et al., 2001, 2005). Moreover,
multiple stressors (e.g., DNA damage, cytokines) induce cellular
ceramide generation through numerous pathways (Cifone et al.,
1994; Takeda et al., 1999; Caricchio et al., 2002; Clarke et al.,
2011), which is directly implicated in organizing a mitochondrialgy 21, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 119
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recruitment and oligomerization in the OMM (Lee et al., 2011).
The requirement for ceramide inDNAdamage-inducedapoptosis
is also evolutionally conserved because the genetic disruption of
ceramide synthase inC. elegans reduces apoptotic responses by
inhibiting the BH3-only protein EGL-1 (Deng et al., 2008).
Not only do stress signals regulate ceramide generation, but
also several reports suggest that BCL-2 proteins themselves
are directly involved in ceramide generation. Epigenetic regula-
tion of BAK revealed that irradiation-induced generation of
distinct ceramide pools was dependent upon BAK expression
(Mullen et al., 2011). Moreover, the inhibition of anti-apoptotic
BCL-2 proteins with ABT-263, a BH3-only protein mimetic, led
to BAK-dependent activation of ceramide synthase that was in-
hibited by MCL-1 (Beverly et al., 2013). Is BAK-dependent regu-
lation of ceramide production contributing to cell death? Within
Beverly et al., the authors suggest that the activated conforma-
tion of BAK promotes ceramide generation, and this phenotype
is independent of BAX. The physiological role of ABT-263
induced, BAK-dependent ceramide generation remains specu-
lation. However, do BH3-only proteins also elicit the same mito-
chondrial response? Is ceramide generation dependent upon
activated monomers of BAK or BAK dimers/oligomers? In addi-
tion, doesmitochondrial generation of ceramide directly alter the
lipid environment of the OMM to affect cellular sensitivity to pro-
apoptotic BCL-2 family function?
Ceramide generation has an important node in sphingolipid
metabolism because ceramide can be reversibly converted
into numerous lipid species, and most of these lipids influence
cellular sensitivity to apoptosis by direct or indirect mechanisms.
Here, we will discuss recent developments on sphingosine-1-
phosphate (S1P) and its metabolic product hexadecenal. We
should mention that the extracellular role of S1P involves binding
to cell surface receptors that transduce anti-apoptotic signals
via transcriptional and posttranslational effects on the BCL-2
family (Limaye et al., 2005; Colie´ et al., 2009). This role is not dis-
cussed here, because our focus is restricted to the direct intra-
cellular effects of S1P and hexadecenal on the BCL-2 family.
Indeed, a growing body of evidence suggests that intracellular
S1P has direct effects on cell death pathways. For example,
the injection of ethanol into neonatal mice results in marked in-
creases in intracellular S1P, which is correlated with sphingosine
kinase 2 (SK2) activation, and apoptosis (Chakraborty et al.,
2012). Curiously, SK2 is localized to mitochondria and may
directly regulate apoptosis through both S1P generation and
via a putative BH3 domain (Liu et al., 2003).
The direct relationships between S1P metabolism and BAK/
BAX activation were elucidated by the demonstration that S1P
and hexadecenal promote BAK and BAX activation, respectively
(Chipuk et al., 2012). In this study, purified mitochondria devoid
of contaminating membrane species (e.g., ER) resisted BID-
induced BAK/BAX-dependent cytochrome c release; and resen-
sitization to BAK/BAX activation was achieved by adding S1P
and hexadecenal, respectively. Furthermore, hexadecenal can
directly bind BAX to promote conformational changes associ-
ated with activation, oligomerization, and pore formation in mito-
chondria and LUVs (Chipuk et al., 2012). Indeed, a role for
hexadecenal in apoptosis has been suggested throughout the
literature. S1P lyase (SPL), the enzyme that catalyzes the degra-120 Chemistry & Biology 21, January 16, 2014 ª2014 Elsevier Ltd Alldation of S1P to hexadecenal, sensitizes to p53-mediated
apoptosis (Oskouian et al., 2006). Hexadecenal also causes
cytoskeletal reorganization and triggers the mitochondrial
pathway of apoptosis via BID and BIM activation, and BAX-
dependent cytochrome c release (Kumar et al., 2011a). A rela-
tionship between SPL and DNA damage is also characterized
by cell cycle arrest, depletion of S1P, and apoptosis (Kumar
et al., 2011b).
Perspectives
Returning to one of our initial questions: how do mitochondria
communicate a signal to induce cell death? Observations accu-
mulated throughout the past twenty years suggest that BAK/
BAX-dependent MOMP is the key event leading to the initiation
of the mitochondrial pathway of apoptosis. For MOMP to pro-
ceed, monomeric forms of BAK and BAX undergo activation at
the OMM, and this occurs via interactions with the direct acti-
vator BH3-only proteins. Indeed, the OMM is permeabilized
following the activation of BAK/BAX, but evidence provided
here points to a more active role of mitochondria in dictating
whether BAK/BAX can localize, activate, oligomerize, and per-
meabilize mitochondria.
Mitochondrial contributions to BAK/BAX activation likely
include a combination of both passive and active mechanisms.
For example, several OMM proteins (i.e., TOM and MTCH2)
are implicated in localizing BAK/BAX to mitochondria; however,
whether MTCH2 and TOM are actively regulated during cell
death signaling remains to be determined. Likewise, how are
the nonapoptotic and pro-apoptotic roles of MTCH2 and TOM
balanced to preserve survival and/or promote death?
The mechanistic contributions of lipids (including mitochon-
dria-specific, i.e., CL; and ubiquitous, e.g., PE) to BAK/BAX acti-
vation and cellular sensitivity to apoptosis remain an outstanding
question. The requirement for CL in certain systemsmay suggest
that distinct apoptotic pathways or BCL-2 family complexes
differentially require CL-mediated BAK/BAX activation and olig-
omerization. Are there prosurvival or pro-apoptotic signaling
events that directly influence the composition of the OMM to
dictate cellular responses? This situation is further complicated
by a significant literature describing multiple lipid species (e.g.,
ceramide, S1P) that have diverse outcomes on both anti-
apoptotic and pro-apoptotic BCL-2 family function (Maceyka
et al., 2005; Mullen and Obeid, 2012). The answers to many of
these questions will likely result from biochemical and cellular
experiments that reveal all the potential cellular interactions
between mitochondria and additional membrane compartments
that directly influence both the lipid and protein composition
of mitochondrial membranes. Detailed structural analyses are
also required to better understand how lipids directly interact
with pro-apoptotic members of the BCL-2 family. Furthermore,
as multiple members of the mitochondrial dynamics machinery
influence membrane structure by tethering mitochondria to
themselves and other organelles (i.e., Drp1, Mfn2), a more
detailed understanding of how altering Drp1 or the mitofusins
changes mitochondrial membrane composition will also reveal
novel aspects of BAK/BAX activation.
In this review, we highlight the complexity of BAK/BAX activa-
tion and MOMP, and how they are affected by multiple cellular
components. In addition to the well-defined control by therights reserved
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ReviewBCL-2 family of proteins, MOMP is also regulated by the compo-
sition of the OMM. In contrast to Shakespeare’s Othello, whose
demise was instigated by his own misjudgment and inability to
interact with others, mitochondrial communication is likely an
essential component to BAX/BAK activation, MOMP, and
cellular demise. Understanding the complexity by which mito-
chondrial composition is maintained and influenced by cell sur-
vival and cell death pathways will likely reveal novel mediators
of cell fate decisions.
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